Volume 1, Issue 12.
Dr. Kenneth H. Mayer from Harvard discusses the important issues related to Pre-Exposure Prophylaxis (PrEP) in HIV-uninfected individuals at high-risk and reviews the results of several key studies that evaluated the use of PrEP.
Podcast (ehiv): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS